{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:34:59Z","timestamp":1792661699621,"version":"4.5.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1097\/cco.0b013e32835167fc","type":"journal-article","created":{"date-parts":[[2012,2,16]],"date-time":"2012-02-16T08:55:16Z","timestamp":1329382516000},"page":"266-271","source":"Crossref","is-referenced-by-count":24,"title":["Testicular germ cell tumors"],"prefix":"10.1097","volume":"24","author":[{"given":"Heather D.","family":"Mannuel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirupama","family":"Mitikiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maleha","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210128","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/01.ju.0000053866.68623.da","article-title":"Increasing incidence of testicular cancer worldwide: a review.","volume":"170","author":"Huyghe","year":"2003","journal-title":"J Urol"},{"key":"R2-12-20210128","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010.","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"R3-12-20210128","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1002\/ijc.24312","article-title":"Endogenous steroid hormone levels in early pregnancy and risk of testicular cancer in the offspring: a nested case-referent study.","volume":"124","author":"Holl","year":"2009","journal-title":"Int J Cancer"},{"key":"R4-12-20210128","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1016\/j.canep.2011.07.003","article-title":"Perinatal risk factors for childhood testicular germ-cell cancer: a Nordic population-based study.","volume":"35","author":"Stephansson","year":"2011","journal-title":"Cancer Epidemiol"},{"key":"R6-12-20210128","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1002\/cncr.25231","article-title":"Testicular microlithiasis predicts concurrent testicular germ cell tumors and intratubular germ cell neoplasia of unclassified type in adults: a meta-analysis and systematic review.","volume":"116","author":"Tan","year":"2010","journal-title":"Cancer"},{"key":"R8-12-20210128","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/cncr.25499","article-title":"Marijuana use and testicular germ cell tumors.","volume":"117","author":"Trabert","year":"2011","journal-title":"Cancer"},{"key":"R9-12-20210128","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1111\/j.1365-2605.2011.01161.x","article-title":"Genomic gain and over expression of CCL2 correlate with vascular invasion in stage I nonseminomatous testicular germ-cell tumours.","volume":"34","author":"Gilbert","year":"2011","journal-title":"Int J Androl"},{"key":"R10-12-20210128","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1464-410X.2010.09631.x","article-title":"Histopathological and molecular features of late relapses in nonseminomas.","volume":"107","author":"Mayer","year":"2011","journal-title":"BJU Int"},{"key":"R11-12-20210128","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ejca.2010.08.017","article-title":"Polymorphic variation in the androgen receptor gene: association with risk of testicular germ cell cancer and metastatic disease.","volume":"47","author":"Vastermark","year":"2011","journal-title":"Eur J Cancer"},{"key":"R12-12-20210128","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/gcc.20843","article-title":"Minimum regions of genomic imbalance in stage I testicular embryonal carcinoma and association of 22q loss with relapse.","volume":"50","author":"Gilbert","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"R13-12-20210128","doi-asserted-by":"crossref","first-page":"e19198","DOI":"10.1371\/journal.pone.0019198","article-title":"p53 hypersensitivity is the predominant mechanism of the unique responsiveness of testicular germ cell tumor (TGCT) cells to cisplatin.","volume":"6","author":"Gutekunst","year":"2011","journal-title":"PLoS One"},{"key":"R14-12-20210128","doi-asserted-by":"crossref","first-page":"19381","DOI":"10.1074\/jbc.M111.218040","article-title":"Serinethreonine kinase 17A is a novel p53 target gene and modulator of cisplatin toxicity and reactive oxygen species in testicular cancer cells.","volume":"286","author":"Mao","year":"2011","journal-title":"J Biol Chem"},{"key":"R15-12-20210128","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.1002\/cncr.25300","article-title":"Association of PAI-1 gene polymorphism with survival and chemotherapy-related vascular toxicity in testicular cancer.","volume":"116","author":"de Haas","year":"2010","journal-title":"Cancer"},{"key":"R16-12-20210128","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4161\/cbt.11.6.14672","article-title":"GPR30 is overexpressed in postpuberal testicular germ cell tumors.","volume":"11","author":"Franco","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"R17-12-20210128","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/modpathol.2011.6","article-title":"MAGEC2 is a sensitive and novel marker for seminoma: a tissue microarray analysis of 325 testicular germ cell tumors.","volume":"24","author":"Bode","year":"2011","journal-title":"Mod Pathol"},{"key":"R18-12-20210128","doi-asserted-by":"crossref","first-page":"19891","DOI":"10.1073\/pnas.1010307107","article-title":"Testis-specific protein on Y chromosome (TSPY) represses the activity of the androgen receptor in androgen-dependent testicular germ-cell tumors.","volume":"107","author":"Akimoto","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R19-12-20210128","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1200\/JCO.2009.26.4655","article-title":"Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19EORTC 30982 study (ISRCTN27163214).","volume":"29","author":"Oliver","year":"2011","journal-title":"J Clin Oncol"},{"key":"R20-12-20210128","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/jnci\/djq525","article-title":"Randomized trials in 2466 patients with stage I seminoma: patterns of relapse and follow-up.","volume":"103","author":"Mead","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"R21-12-20210128","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1200\/JCO.2010.30.1044","article-title":"Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish Norwegian Testicular Cancer Study Group.","volume":"29","author":"Tandstad","year":"2011","journal-title":"J Clin Oncol"},{"key":"R23-12-20210128","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1200\/JCO.2009.23.0755","article-title":"Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery.","volume":"28","author":"Kollmannsberger","year":"2010","journal-title":"J Clin Oncol"},{"key":"R24-12-20210128","first-page":"531","article-title":"Long-term follow-up of cisplatin combination chemotherapy in patients with disseminated nonseminomatous germ cell tumors: is a postchemotherapy retroperitoneal lymph node dissection needed after complete remission J Clin O","volume":"28","author":"Ehrlich","year":"2010","journal-title":"ncol"},{"key":"R25-12-20210128","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1200\/JCO.2010.32.3204","article-title":"Adverse prognostic factors for testicular cancer-specific survival: a population-based study of 27948 patients.","volume":"29","author":"Fossa","year":"2011","journal-title":"J Clin Oncol"}],"container-title":["Current Opinion in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CCO.0b013e32835167fc","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:38:42Z","timestamp":1786048722000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001622-201205000-00012"}},"subtitle":["biology and clinical update"],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/cco.0b013e32835167fc","relation":{},"ISSN":["1040-8746"],"issn-type":[{"value":"1040-8746","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}